Socioeconomic Inequalities in SARS-CoV-2 Infection and COVID-19 Health Outcomes in Urban Italy During the COVID-19 Vaccine Rollout, January–November 2021
Journal of Urban Health · 2024-04 · 101 (2) · 289-299
DOI: 10.1007/s11524-024-00844-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Urban Health, online erschienen am 18.03.2024. Verfasst von Emmanouil Alexandros Fotakis und 7 weiteren Autor:innen. Beteiligte Einrichtung: European Programme On Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, Stockholm, Sweden. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Socioeconomic Factors, SARS-CoV-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU-MUR-PNRR Extended Partnership initiative on Emerging Infectious Diseases.
Abstract (Originalsprache)
This study analysed the evolution of the association of socioeconomic deprivation (SED) with SARS-CoV-2 infection and COVID-19 outcomes in urban Italy during the vaccine rollout in 2021. We conducted a retrospective cohort analysis between January and November 2021, comprising of 16,044,530 individuals aged ≥ 20 years, by linking national COVID-19 surveillance system data to the Italian SED index calculated at census block level. We estimated incidence rate ratios (IRRs) of infection and severe COVID-19 outcomes by SED tercile relative to the least deprived tercile, over three periods defined as low (0–10%); intermediate (> 10–60%) and high (> 60–74%) vaccination coverage. We found patterns of increasing relative socioeconomic inequalities in infection, hospitalisation and death as COVID-19 vaccination coverage increased. Between the low and high coverage periods, IRRs for the most deprived areas increased from 1.09 (95%CI 1.03–1.15) to 1.28 (95%CI 1.21–1.37) for infection; 1.48 (95%CI 1.36–1.61) to 2.02 (95%CI 1.82–2.25) for hospitalisation and 1.57 (95%CI 1.36–1.80) to 1.89 (95%CI 1.53–2.34) for death. Deprived populations in urban Italy should be considered as vulnerable groups in future pandemic preparedness plans to respond to COVID-19 in particular during mass vaccination roll out phases with gradual lifting of social distancing measures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- European Programme On Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, Stockholm, Sweden.
- Department of Infectious Diseases, Istituto Superiore Di Sanità, Rome, Italy.
- Department of Infectious Diseases, Istituto Superiore Di Sanità, Rome, Italy. patrizio.pezzotti@iss.it.
ORCID-Profile: Patrizio Pezzotti
Förderung
- NextGenerationEU-MUR-PNRR Extended Partnership initiative on Emerging Infectious Diseases
Zitieren
APA
Fotakis, E. A., Mateo-Urdiales, A., Fabiani, M., Sacco, C., Petrone, D., Riccardo, F., Bella, A., & Pezzotti, P. (2024). Socioeconomic Inequalities in SARS-CoV-2 Infection and COVID-19 Health Outcomes in Urban Italy During the COVID-19 Vaccine Rollout, January–November 2021. Journal of Urban Health, 101(2), 289-299. https://doi.org/10.1007/s11524-024-00844-0
Vancouver
Fotakis EA, Mateo-Urdiales A, Fabiani M, Sacco C, Petrone D, Riccardo F, et al. Socioeconomic Inequalities in SARS-CoV-2 Infection and COVID-19 Health Outcomes in Urban Italy During the COVID-19 Vaccine Rollout, January–November 2021. Journal of Urban Health. 2024;101(2):289-299. doi:10.1007/s11524-024-00844-0
BibTeX
@article{Fotakis2024,
author = {Fotakis, Emmanouil Alexandros and Mateo-Urdiales, Alberto and Fabiani, Massimo and Sacco, Chiara and Petrone, Daniele and Riccardo, Flavia and Bella, Antonino and Pezzotti, Patrizio},
title = {Socioeconomic Inequalities in SARS-CoV-2 Infection and COVID-19 Health Outcomes in Urban Italy During the COVID-19 Vaccine Rollout, January–November 2021},
journal = {Journal of Urban Health},
year = {2024},
volume = {101},
number = {2},
pages = {289--299},
doi = {10.1007/s11524-024-00844-0}
}
EUVIMED